ANKRD45
gene geneOn this page
Also known as FLJ45235CT117
Summary
ANKRD45 (ankyrin repeat domain 45, HGNC:24786) is a protein-coding gene on chromosome 1q25.1, encoding Ankyrin repeat domain-containing protein 45 (Q5TZF3). May play a role during cell division.
Involved in cell population proliferation. Located in several cellular components, including centrosome; cleavage furrow; and midbody.
Source: NCBI Gene 339416 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 51 total — 3 pathogenic
- MANE Select transcript:
NM_198493
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24786 |
| Approved symbol | ANKRD45 |
| Name | ankyrin repeat domain 45 |
| Location | 1q25.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ45235, CT117 |
| Ensembl gene | ENSG00000183831 |
| Ensembl biotype | protein_coding |
| OMIM | 618712 |
| Entrez | 339416 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 retained_intron
ENST00000333279, ENST00000367712, ENST00000924220
RefSeq mRNA: 1 — MANE Select: NM_198493
NM_198493
CCDS: CCDS1309
Canonical transcript exons
ENST00000333279 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001300567 | 173624787 | 173624925 |
| ENSE00001317942 | 173646846 | 173647013 |
| ENSE00001322321 | 173627065 | 173627159 |
| ENSE00002143632 | 173669817 | 173669851 |
| ENSE00002172650 | 173608336 | 173610215 |
| ENSE00002248306 | 173659091 | 173659433 |
Expression profiles
Bgee: expression breadth ubiquitous, 137 present calls, max score 95.41.
FANTOM5 (CAGE): breadth broad, TPM avg 0.9714 / max 114.8289, expressed in 278 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 15951 | 0.9714 | 278 |
Top tissues by expression
234 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sperm | CL:0000019 | 95.41 | gold quality |
| bronchial epithelial cell | CL:0002328 | 90.48 | gold quality |
| bronchus | UBERON:0002185 | 88.50 | gold quality |
| cortical plate | UBERON:0005343 | 85.70 | gold quality |
| secondary oocyte | CL:0000655 | 84.01 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.64 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 81.72 | gold quality |
| oviduct epithelium | UBERON:0004804 | 81.66 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 77.65 | gold quality |
| oocyte | CL:0000023 | 76.82 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 74.13 | gold quality |
| right uterine tube | UBERON:0001302 | 74.10 | gold quality |
| fallopian tube | UBERON:0003889 | 73.11 | gold quality |
| ventricular zone | UBERON:0003053 | 72.20 | gold quality |
| ganglionic eminence | UBERON:0004023 | 71.15 | gold quality |
| adult organism | UBERON:0007023 | 70.44 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 70.43 | gold quality |
| caudate nucleus | UBERON:0001873 | 68.70 | gold quality |
| nucleus accumbens | UBERON:0001882 | 67.68 | gold quality |
| testis | UBERON:0000473 | 67.63 | gold quality |
| left testis | UBERON:0004533 | 66.44 | gold quality |
| prefrontal cortex | UBERON:0000451 | 66.40 | gold quality |
| right testis | UBERON:0004534 | 66.16 | gold quality |
| putamen | UBERON:0001874 | 64.98 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 62.61 | gold quality |
| islet of Langerhans | UBERON:0000006 | 62.36 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 61.74 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 61.37 | gold quality |
| amygdala | UBERON:0001876 | 61.22 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 61.14 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.56 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
112 targeting ANKRD45, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-548AE-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-548AH-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AM-3P | 99.93 | 72.54 | 4872 |
| HSA-MIR-548AQ-3P | 99.93 | 72.66 | 4867 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-6768-5P | 99.92 | 67.36 | 1942 |
| HSA-MIR-338-5P | 99.92 | 72.34 | 2951 |
| HSA-MIR-627-3P | 99.90 | 71.42 | 3316 |
| HSA-MIR-302A-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302B-3P | 99.89 | 71.23 | 1777 |
| HSA-MIR-302C-3P | 99.89 | 71.20 | 1778 |
Literature-anchored findings (GeneRIF, showing 1)
- we show that the distribution of ANKRD45 protein was highly dynamic during mitosis. ANKRD45 is preferably localized to the midbody ring during cytokinesis. Together, our results suggest that Ankrd45 is a novel ankyrin repeat protein with a conserved role during cell proliferation in both zebrafish embryos and mammalian cells (PMID:31208154)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ankrd45 | ENSDARG00000011326 |
| mus_musculus | Ankrd45 | ENSMUSG00000044835 |
| rattus_norvegicus | Ankrd45 | ENSRNOG00000002890 |
| drosophila_melanogaster | Tnks | FBGN0027508 |
| caenorhabditis_elegans | tnsl-1 | WBGENE00010498 |
Paralogs (2): TNKS2 (ENSG00000107854), TNKS (ENSG00000173273)
Protein
Protein identifiers
Ankyrin repeat domain-containing protein 45 — Q5TZF3 (reviewed: Q5TZF3)
All UniProt accessions (1): Q5TZF3
UniProt curated annotations — full annotation on UniProt →
Function. May play a role during cell division.
Subcellular location. Cytoplasm. Midbody. Midbody ring. Cleavage furrow.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5TZF3-2 | 1 | yes |
| Q5TZF3-1 | 2 |
RefSeq proteins (1): NP_940895* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR029048 | HSP70_C_sf | Homologous_superfamily |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR050776 | Ank_Repeat/CDKN_Inhibitor | Family |
Pfam: PF12796
UniProt features (7 total): repeat 2, compositionally biased region 2, chain 1, region of interest 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5TZF3-F1 | 81.12 | 0.60 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 78 (showing top):
EFC_Q6, RFX1_02, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, GOCC_CELL_DIVISION_SITE, GOCC_MIDBODY, GOCC_PLASMA_MEMBRANE_REGION, DODD_NASOPHARYNGEAL_CARCINOMA_DN, chr1q25, GOCC_CLEAVAGE_FURROW, GOCC_FLEMMING_BODY, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN, CHAMP1_TARGET_GENES, MIR4728_5P, MIR6785_5P
GO Biological Process (1): cell population proliferation (GO:0008283)
GO Molecular Function (2): molecular_function (GO:0003674), protein binding (GO:0005515)
GO Cellular Component (7): cytoplasm (GO:0005737), centrosome (GO:0005813), cytosol (GO:0005829), plasma membrane (GO:0005886), midbody (GO:0030496), cleavage furrow (GO:0032154), Flemming body (GO:0090543)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 4 |
| cellular process | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
| cytoplasm | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cell division site | 1 |
| plasma membrane region | 1 |
| midbody | 1 |
Protein interactions and networks
STRING
3369 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ANKRD45 | TEX50 | A0A1B0GTY4 | 633 |
| ANKRD45 | ADAMTS18 | Q8TE60 | 515 |
| ANKRD45 | ZBTB37 | Q5TC79 | 512 |
| ANKRD45 | FAM153B | P0C7A2 | 480 |
| ANKRD45 | KIAA0040 | Q15053 | 476 |
| ANKRD45 | FAM218A | Q96MZ4 | 447 |
| ANKRD45 | ZBED11 | P0CF97 | 433 |
| ANKRD45 | SLC9C2 | Q5TAH2 | 432 |
| ANKRD45 | ACTR8 | Q9H981 | 432 |
| ANKRD45 | MAGEB3 | O15480 | 422 |
| ANKRD45 | PCDHA4 | Q9UN74 | 413 |
| ANKRD45 | CENPL | Q8N0S6 | 410 |
| ANKRD45 | CDK4 | P11802 | 407 |
| ANKRD45 | C1orf198 | Q9H425 | 407 |
| ANKRD45 | GOLGA6L10 | A6NI86 | 402 |
IntAct
5 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAGEA2B | ANKRD45 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ANKRD45 | PDIA6 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (7): ANKRD45 (Two-hybrid), ANKRD45 (Two-hybrid), ANKRD45 (Two-hybrid), MAGEA2 (Two-hybrid), ANKRD45 (Proximity Label-MS), ANKRD45 (Two-hybrid), APP (Reconstituted Complex)
ESM2 similar proteins: A5D7S3, A5PKL6, A6NHR9, A6NNW6, A6QPQ5, A6QPR9, A8K855, O02789, O75717, P27641, P59328, P60670, P82933, Q0IHV1, Q2T9V5, Q32KZ1, Q496Z9, Q4R6C7, Q4R6Y8, Q58DQ5, Q5F204, Q5M882, Q5R5T0, Q5R952, Q5RL51, Q5TZF3, Q69ZX6, Q6AZN0, Q6DDT5, Q6P5D8, Q7Z2T5, Q8CE96, Q8NEC7, Q8R3N6, Q8TAT6, Q8VDY4, Q8VI84, Q8WTT2, Q91Y26, Q96FV9
Diamond homologs: A0A0D1CD96, A0A509AJG0, A2Q0Z1, B0S794, P08108, P11142, P12794, P19120, P19208, P19378, P40918, P63017, P63018, P78695, Q05866, Q05944, Q5NVM9, Q5TZF3, Q5U464, Q71U34, Q8T869, Q90473, Q90593, G3I8R9, P05456, P06761, P07823, P11021, P20029, P59769, P83616, P83617, Q0VCX2, Q3S4T7, Q5R4P0, Q810N6, Q91883, Q24798, Q24895
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
51 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 3 |
| Likely pathogenic | 0 |
| Uncertain significance | 42 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (3)
| Variant ID | HGVS | Classification |
|---|---|---|
| 148038 | GRCh38/hg38 1q24.2-25.2(chr1:169218236-178075834)x1 | Pathogenic |
| 1527393 | GRCh37/hg19 1q24.3-25.1(chr1:171881608-175899893) | Pathogenic |
| 60046 | GRCh38/hg38 1q24.2-25.1(chr1:168314822-175299299)x1 | Pathogenic |
SpliceAI
1096 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:173610214:ACC:A | acceptor_loss | 1.0000 |
| 1:173610215:CCTGA:C | acceptor_loss | 1.0000 |
| 1:173610216:C:A | acceptor_loss | 1.0000 |
| 1:173610216:C:CC | acceptor_gain | 1.0000 |
| 1:173610217:T:G | acceptor_loss | 1.0000 |
| 1:173624780:AACTT:A | donor_loss | 1.0000 |
| 1:173624783:TTAC:T | donor_loss | 1.0000 |
| 1:173624784:T:TG | donor_loss | 1.0000 |
| 1:173624785:A:AC | donor_gain | 1.0000 |
| 1:173624785:AC:A | donor_loss | 1.0000 |
| 1:173624786:C:A | donor_loss | 1.0000 |
| 1:173624786:C:CT | donor_gain | 1.0000 |
| 1:173624786:CAT:C | donor_gain | 1.0000 |
| 1:173624786:CATG:C | donor_gain | 1.0000 |
| 1:173624786:CATGG:C | donor_gain | 1.0000 |
| 1:173624921:GTATT:G | acceptor_gain | 1.0000 |
| 1:173624922:TATT:T | acceptor_gain | 1.0000 |
| 1:173624924:TT:T | acceptor_gain | 1.0000 |
| 1:173624925:TCTA:T | acceptor_loss | 1.0000 |
| 1:173624926:C:CA | acceptor_loss | 1.0000 |
| 1:173624926:C:CC | acceptor_gain | 1.0000 |
| 1:173627060:AGTAC:A | donor_loss | 1.0000 |
| 1:173627061:GTAC:G | donor_loss | 1.0000 |
| 1:173627062:TA:T | donor_loss | 1.0000 |
| 1:173627063:A:T | donor_loss | 1.0000 |
| 1:173627064:CCTTG:C | donor_loss | 1.0000 |
| 1:173627160:C:CC | acceptor_gain | 1.0000 |
| 1:173659314:AGGG:A | donor_gain | 1.0000 |
| 1:173659431:TACC:T | acceptor_loss | 1.0000 |
| 1:173659432:ACCTA:A | acceptor_loss | 1.0000 |
AlphaMissense
1749 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:173646893:G:T | A150D | 0.991 |
| 1:173646989:G:T | A118E | 0.990 |
| 1:173646922:G:C | N140K | 0.988 |
| 1:173646922:G:T | N140K | 0.988 |
| 1:173646990:C:G | A118P | 0.986 |
| 1:173659166:A:G | C85R | 0.982 |
| 1:173646986:G:T | A119D | 0.981 |
| 1:173646992:G:T | A117D | 0.980 |
| 1:173659164:G:C | C85W | 0.980 |
| 1:173646984:A:G | W120R | 0.978 |
| 1:173646984:A:T | W120R | 0.978 |
| 1:173659185:T:A | R78S | 0.978 |
| 1:173659185:T:G | R78S | 0.978 |
| 1:173646849:C:G | A165P | 0.975 |
| 1:173624889:A:G | W210R | 0.974 |
| 1:173624889:A:T | W210R | 0.974 |
| 1:173646857:A:G | L162P | 0.974 |
| 1:173646894:C:G | A150P | 0.974 |
| 1:173646905:G:T | A146D | 0.973 |
| 1:173624831:A:G | L229P | 0.971 |
| 1:173627144:A:G | L171P | 0.970 |
| 1:173646982:C:A | W120C | 0.970 |
| 1:173646982:C:G | W120C | 0.970 |
| 1:173646987:C:G | A119P | 0.970 |
| 1:173646956:A:G | L129P | 0.967 |
| 1:173659165:C:T | C85Y | 0.966 |
| 1:173627157:C:G | A167P | 0.963 |
| 1:173646857:A:T | L162Q | 0.960 |
| 1:173646859:G:C | F161L | 0.960 |
| 1:173646859:G:T | F161L | 0.960 |
dbSNP variants (sampled 300 via entrez): RS1000000710 (1:173680455 C>T), RS1000003492 (1:173634713 A>G), RS1000014316 (1:173676470 C>T), RS1000062888 (1:173679887 C>A), RS1000076873 (1:173609868 G>T), RS1000106268 (1:173618931 G>A), RS1000115791 (1:173715778 A>G), RS1000142691 (1:173656529 G>A), RS1000241759 (1:173686417 G>A), RS1000268664 (1:173627771 T>A), RS1000269357 (1:173637181 G>A), RS1000294839 (1:173671653 G>A), RS1000318334 (1:173673383 G>A), RS1000346202 (1:173621787 G>C), RS1000352343 (1:173612740 G>A)
Disease associations
OMIM: gene MIM:618712 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004863_47 | Mosquito bite size | 3.000000e-06 |
| GCST006269_1217 | General cognitive ability | 4.000000e-08 |
| GCST006940_115 | Neurociticism | 2.000000e-09 |
| GCST006952_13 | Feeling tense | 3.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008378 | mosquito bite reaction size measurement |
| EFO:0004337 | intelligence |
| EFO:0007660 | neuroticism measurement |
| EFO:0009596 | feeling tense measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
15 total (human), top 15 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | increases expression, affects methylation, increases abundance | 2 |
| Valproic Acid | affects expression, decreases methylation | 2 |
| bisphenol A | affects cotreatment, increases methylation | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Fulvestrant | affects cotreatment, increases methylation | 1 |
| Vorinostat | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Nitrogen Dioxide | affects methylation, increases abundance | 1 |
| Oxygen | increases expression | 1 |
| Phthalic Acids | decreases methylation | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Particulate Matter | affects methylation, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.